Related Experiment Video
Updated: Jun 13, 2025

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Dual role of triglyceride structures facilitates anti-tumor drug delivery: Both as a self-assembling module and a
Wenxin Zhong1, Yalin Xu2, Zixuan Wang2
1Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang, Liaoning 110016, China.
Abstract:
Small molecule prodrugs self-assembled nano-delivery systems with tumor responsive linkages are emerging as an effective platform. However, the heterogeneity of tumor microenvironment may limit the anti-tumor effect of prodrug nanomedicines with a single response module. Here, we chose disulfide bond as the response module and branched chain alcohol as the self-assembly modification module to construct a single-responsive prodrug. We also constructed a double-responsive paclitaxel prodrug combining triglyceride and disulfide bond, taking into account of the highly expressed lipase and glutathione levels in tumor cells. The results showed that the anti-tumor effect of single-responsive branched chain alcohol modified prodrug nanoparticles was inferior to triglyceride prodrug nanoparticles with dual response modules. The triglyceride structure can not only serve as a self-assembly modification module, but also serve as a response module for intelligent drug release in tumor. Such dual roles will facilitate the efficient delivery of small molecule self-assembled prodrugs to tumor sites.
Insights
Dual-responsive nanomedicines utilizing triglyceride and disulfide bonds show superior anti-tumor effects compared to single-responsive systems. This dual-response strategy enhances targeted drug delivery for small molecule prodrugs.
Area of Science:
- Nanomedicine
- Drug Delivery Systems
- Prodrug Nanoparticles
Background:
- Self-assembled nano-delivery systems using small molecule prodrugs with tumor-responsive linkages show promise for cancer therapy.
- Tumor microenvironment heterogeneity can limit the efficacy of single-responsive prodrug nanomedicines.
- Tumor cells often exhibit high levels of glutathione and lipase, presenting opportunities for targeted drug release.
Purpose of the Study:
- To construct and evaluate single-responsive and dual-responsive prodrug nanoparticles for enhanced anti-tumor effects.
- To investigate the role of triglyceride and disulfide bonds as response modules in nanomedicine.
- To compare the anti-tumor efficacy of single-responsive versus dual-responsive prodrug nanoparticles.
Main Methods:
- Development of a single-responsive prodrug nanoparticle using disulfide bonds as the response module and branched chain alcohol for self-assembly.
- Construction of a dual-responsive paclitaxel prodrug nanoparticle by combining triglyceride and disulfide bonds.
- Evaluation of the anti-tumor effects of both single-responsive and dual-responsive prodrug nanoparticles.
Main Results:
- The single-responsive branched chain alcohol-modified prodrug nanoparticles exhibited inferior anti-tumor effects.
- The triglyceride-based prodrug nanoparticles with dual response modules demonstrated superior anti-tumor efficacy.
- Triglyceride structures function effectively as both self-assembly modules and tumor-responsive drug release triggers.
Conclusions:
- Dual-responsive prodrug nanoparticles, particularly those incorporating triglyceride structures, offer enhanced anti-tumor effects compared to single-responsive systems.
- The dual functionality of triglyceride structures (self-assembly and tumor-responsive release) facilitates efficient delivery of small molecule prodrugs to tumor sites.
- This dual-response strategy holds significant potential for improving the efficacy of nanomedicines in cancer treatment.
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Drug Distribution: Tissue Binding
For...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drug Delivery: Enteral Route

